Latest / JACC Specialty Journals
JACC: CardioOncology - Preventing Cardiac Damage In Patients Treated For Breast Cancer And Lymphoma: The PROACT Clinical Trial
In this episode of the JACC: CardioOncology Podcast, Antonio Cannata discusses the PROACT clinical trial, which investigated the effectiveness of enalapril in preventing cardiac damage in breast cancer and lymphoma patients undergoing anthracycline therapy. Despite neutral results, the conversation delves into the challenges of defining myocardial injury and emphasizes the need for improved risk stratification and innovative trial designs in future research.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.